2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$131.06+$1.22 (+0.94%)
Price as of Jul 13, 2026 7:15 PM EDT- $161.2BMarket Cap
- 21.50%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$131.06+$1.22 (+0.94%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $129.83 | ||
Change | -$5.01 (-3.72%) | ||
Open | $134.02 | ||
High | $134.97 | ||
Low | $129.26 | ||
Previous Close | $134.84 | ||
Volume | 5,935,999 | ||
30-Day Average Volume | 8,689,994 | ||
1-Week Change | -1.10% | ||
1-Month Change | 7.58% | ||
1-Year Change | 21.50% | ||
3-Year Change | 89.31% | ||
5-Year Change | 128.41% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $56.3B | ||
Market Cap | $161.2B | ||
Enterprise Value | $175.7B | ||
Period: QTR TTM FY | |||
Revenue | $6.9B | ||
Net Income | $2.0B | ||
Free Cash Flow | $2.4B | ||
EBIT | $2.6B | ||
EBITDA | $2.7B | ||
Net Working Capital | $9.2B | ||
EPS | $1.61 | ||
Enterprise Value/EBITDA | 66 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 7 | ||
P/E | 81 | ||
PEG | -11 | ||
Price/Free Cash Flow | 66 | ||
Price/Operating Cash Flow | 63 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.53% | ||
Trailing Annual Dividend Yield | 2.48% | ||
Ex-Dividend Date | 06/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield